Company & Sponsor Intelligence

University of Kansas Medical Center

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials13

Recruiting1

Completed12

Countries1

Therapeutic footprint

alzheimersautismepilepsyother_neurologyparkinsons

Indexed studies

NCT02950636Effect of Yoga on Mood and Quality of Life in Patients With Refractory Epilepsy
epilepsy · United StatesNA

NCT03690193Feasibility and Efficacy of the Ketogenic Diet in Alzheimer's Disease
alzheimers · NA

NCT05024916Blueberry Intervention Study for Brain Aging
other_neurology · United StatesNA

NCT02000583Alzheimer's Prevention Through Exercise
alzheimers · United StatesNA

NCT05383833Creatine to Augment Bioenergetics in Alzheimer's
alzheimers · United StatesNA

NCT02921672Feasibility Trial of a Mediterranean Diet Pattern to Prevent Cognitive Decline
alzheimers · United StatesNA

NCT01741701A Pilot Study of Oxaloacetate in Subjects With Treated PD
parkinsons · United StatesPHASE2, PHASE3

NCT07463755Low-Fidelity Driving Simulator Training in Parkinson's Disease.
parkinsons · United StatesNA

NCT05277103Exploring Predictors of Response to a Peer-Mediated Intervention for Preschoolers With ASD
autism · United StatesNA

NCT03954210SIESTA: Sleep Intervention to Enhance Cognitive Status and Reduce Beta Amyloid
alzheimers · United StatesNA

NCT02928068Telehealth Coaching for Families of Children With Autism
autism · United StatesNA

NCT05207397Lactate for Energy and Neurocognition
alzheimers · United StatesCOMPLETED

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →